Exploration of Non-traditional Therapeutics: Antibody Drug Conjugates


120 minutes

Speakers

Anu Connor, Ph.D. - Director Preclinical Safety, Novartis
Barbara Hibner, Ph.D. - CEO, PercepTx
Paul Jaminet, Ph.D. - Founder and CEO, Angiex
Richard Gregory, Ph.D. - Executive Vice President and Chief Scientific Officer, Immunogen
Timothy B. Lowinger, Ph.D. - Chief Scientific Officer, Mersana Therapeutics